| 中文名称: | (Z)-3-(2,4-二甲基-5-((2-氧代吲哚啉-3-亚基)甲基)-1H-吡咯-3-基)丙酸 |
| 中文别名: | 抗癌医药中间体;(Z)-3-(2,4-二甲基-5-((2-氧代吲哚啉-3-亚基)甲基)-1H-吡咯-3-基)丙酸;5-[(Z)-(1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基]-2,4-二甲基-1H-吡咯-3-丙酸 |
| smiles: | O=C1/C(/C2=C([H])C([H])=C([H])C([H])=C2N1[H])=C(/[H])\C1=C(C([H])([H])[H])C(C([H])([H])C([H])([H])C(=O)O[H])=C(C([H])([H])[H])N1[H] |
| 英文名称: | SU6668 |
| 英文别名: | (Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid;(Z)-3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoic acid;3-[2,4-dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl]propionic acid;PDGFR Tyrosine Kinase Inhibitor VI, SU6668;SU 6668;SU-6668;1H-Pyrrole-3-propanoic acid, 5-((1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-;1H-Pyrrole-3-propanoic acid, 5-[(Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-;3-(2,4-Dimethyl-5-((2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propionic acid;3-(2,4-Dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid;Orantinib;SU6668;TSU 68;TSU68;9RL37ZZ665;2,4-Dimethyl-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-pyrrole-3-propanoic acid;3-(2,4-Dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid;Orantinibum;3-(2,4-dimethyl-5-{[(3Z)-2-oxo-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid;3-[2,4;(Z)-Orantinib |
| CAS号: | 210644-62-5 |
| 分子式: | C18H18N2O3 |
| 分子量: | 310.35 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
(Z)-3-(2,4-二甲基-5-((2-氧代吲哚啉-3-亚基)甲基)-1H-吡咯-3-基)丙酸
英文名:
SU6668
别名:抗癌医药中间体;(Z)-3-(2,4-二甲基-5-((2-氧代吲哚啉-3-亚基)甲基)-1H-吡咯-3-基)丙酸;5-[(Z)-(1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基]-2,4-二甲基-1H-吡咯-3-丙酸
商品编号:R060561-100mg
规格:100mg
纯度:97%
CAS号: 210644-62-5
分子式:C18H18N2O3
分子量:310.35
| 价格 |
¥ 958.00
(请 登录 会员查看折扣价)
|
| 货期 | 现货 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















